We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $3.89B
1-Year Est. Return 16.15%
This Fund
S&P 500
This Quarter Est. Return
-13.93%
1 Year Est. Return
+16.15%
3 Year Est. Return
+48.47%
5 Year Est. Return
+55.5%
10 Year Est. Return
+378.36%
AUM
$9.84B
AUM Growth
-$1.44B
Cap. Flow
+$331M
Cap. Flow %
3.36%
Top 10 Hldgs %
19.04%
Holding
125
New
7
Increased
65
Reduced
46
Closed
6

Top Buys

Rank Stock Value
1
NTNX icon
Nutanix
NTNX
+$99.3M
2
BF.B icon
Brown-Forman Class B
BF.B
+$68.2M
3
NEWR
New Relic, Inc.
NEWR
+$57.8M
4
CMD
Cantel Medical Corporation
CMD
+$54.9M
5
BL icon
BlackLine
BL
+$53.6M

Top Sells

Rank Stock Value
1
HRL icon
Hormel Foods
HRL
+$90.6M
2
HELE icon
Helen of Troy
HELE
+$67.3M
3
RHT
Red Hat Inc
RHT
+$53.2M
4
DATA
Tableau Software, Inc.
DATA
+$48.6M
5
NUVA
NuVasive, Inc.
NUVA
+$37.1M

Sector Composition

Rank Sector Weight
1 Healthcare 22.08%
2 Technology 21.1%
3 Industrials 16.12%
4 Financials 14.2%
5 Consumer Staples 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOGM
26
DELISTED
LogMein, Inc.
LOGM
$121M 1.23%
1,486,235
-46,320
-3% -$3.91M
CTLT
27
DELISTED
CATALENT, INC.
CTLT
$120M 1.22%
3,838,830
-62,415
-2% -$2.41M
ULTA icon
28
Ulta Beauty
ULTA
$23.2B
$118M 1.2%
482,835
+36,925
+8% +$10.2M
FLO icon
29
Flowers Foods
FLO
$1.29B
$114M 1.16%
6,182,485
-1,022,180
-14% -$19.6M
HRL icon
30
Hormel Foods
HRL
$11.5B
$113M 1.15%
2,650,670
-2,103,095
-44% -$90.6M
SJM icon
31
J.M. Smucker
SJM
$13B
$113M 1.15%
1,208,640
+310,995
+35% +$32.5M
IFF icon
32
International Flavors & Fragrances
IFF
$21.5B
$113M 1.15%
840,935
+13,440
+2% +$1.86M
ROK icon
33
Rockwell Automation
ROK
$46.4B
$109M 1.11%
725,565
+55,560
+8% +$9.27M
AME icon
34
Ametek
AME
$53.8B
$108M 1.1%
1,596,535
+88,650
+6% +$6.36M
XRAY icon
35
Dentsply Sirona
XRAY
$1.99B
$105M 1.06%
2,810,240
+297,545
+12% +$10.8M
ARGO
36
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$104M 1.06%
1,552,563
-122,130
-7% -$7.92M
VEEV icon
37
Veeva Systems
VEEV
$43.3B
$104M 1.05%
1,159,000
-129,210
-10% -$11.8M
EW icon
38
Edwards Lifesciences
EW
$49.4B
$103M 1.04%
2,011,530
+34,635
+2% +$1.75M
TECH icon
39
Bio-Techne
TECH
$11.3B
$102M 1.04%
2,832,400
+455,860
+19% +$19M
AAP icon
40
Advance Auto Parts
AAP
$2.63B
$102M 1.03%
646,630
+2,245
+0.3% +$375K
SXT icon
41
Sensient Technologies
SXT
$5.4B
$101M 1.02%
1,803,185
+111,510
+7% +$7.29M
MKC icon
42
McCormick & Company Non-Voting
MKC
$13.5B
$101M 1.02%
1,443,680
-359,610
-20% -$25.8M
NTNX icon
43
Nutanix
NTNX
$18.4B
$100M 1.02%
+2,404,770
New +$99.3M
TAP icon
44
Molson Coors Class B
TAP
$7.39B
$99.4M 1.01%
1,769,485
+83,690
+5% +$5.15M
COO icon
45
Cooper Companies
COO
$10.1B
$99.1M 1.01%
1,558,040
-204,660
-12% -$13.2M
IEX icon
46
IDEX
IEX
$16.4B
$98.6M 1%
780,965
+337,940
+76% +$45.2M
AVNS
47
DELISTED
Avanos Medical
AVNS
$94M 0.96%
2,097,972
+531,976
+34% +$27.9M
CNMD icon
48
CONMED
CNMD
$1.4B
$91.3M 0.93%
1,422,180
+46,525
+3% +$3.18M
LH icon
49
Labcorp
LH
$26.4B
$89.3M 0.91%
822,890
+2,532
+0.3% +$339K
UMBF icon
50
UMB Financial
UMBF
$10.4B
$86.3M 0.88%
1,415,210
+103,195
+8% +$6.69M
1
2
3 4 5

Similar funds

NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $3.89B AUM
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $3.9B AUM
AC
Anther Capital Hong Kong $3.91B AUM

Champlain Investment Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Champlain Investment Partners held 125 positions worth $9.84B, down 13% from $11.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Champlain Investment Partners deployed $331M of net new capital in Q4 2018, opening 7 new positions and adding to 65 existing holdings. Its largest new stake was Nutanix: 2,404,770 shares worth $100M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Hormel Foods, an estimated $90.6M trimmed.

  • Champlain Investment Partners's largest Q4 2018 buy was Nutanix: 2,404,770 shares worth $100M.
  • Champlain Investment Partners added most to New Relic, Inc. in Q4 2018, an estimated $57.8M increase.
  • Champlain Investment Partners's biggest Q4 2018 reduction was Hormel Foods, cutting an estimated $90.6M.
  • Champlain Investment Partners fully exited MINDBODY, Inc. Class A Common Stock in Q4 2018, selling an estimated $16M.
  • Champlain Investment Partners's ten largest holdings make up 19% of its $9.84B portfolio in Q4 2018.
  • Champlain Investment Partners opened 7 new positions and closed 6 in Q4 2018.
  • Champlain Investment Partners's portfolio value fell 13% quarter-over-quarter to $9.84B.

Based on Champlain Investment Partners's 13F filing for Q4 2018, filed 13 Feb 2019.